Drug interaction between sevelamer and cyclosporin.
Guillen-Anaya
Miguel-Angel
MA
Jadoul
Michel
M
D000368:Aged; D016572:Cyclosporine / Q000009:adverse effects* / Q000627:therapeutic use; D004066:Digestive System Diseases / Q000139:chemically induced*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004347:Drug Interactions; D004852:Epoxy Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D017093:Liver Failure / Q000150:complications / Q000175:diagnosis / Q000601:surgery; D016031:Liver Transplantation; D010760:Phosphorus Metabolism Disorders / Q000188:drug therapy / Q000209:etiology; D011073:Polyamines; D011095:Polyethylenes / Q000009:adverse effects* / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects; D018570:Risk Assessment; D000069603:Sevelamer
D004852:Epoxy Compounds; D011073:Polyamines; D011095:Polyethylenes; D016572:Cyclosporine; D000069603:Sevelamer